FDA extends review for Salix diarrhea drug
(Reuters) - Salix Pharmaceuticals Ltd said U.S. health regulators have extended the review date by three months for its experimental pill for HIV therapy-related diarrhea. The U.S. Food And Drug Administration was to review the drug, crofelemer, on June 5. The FDA has notified Salix that it requires additional time for a full review but did not seek any additional studies, the company said in a statement. Salix holds the North American and European rights to the drug. ... read more..
source:http://yhoo.it/Jz2Y78
No comments:
Post a Comment